img

Global NK Cells Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global NK Cells Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

NK Cells report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global NK Cells market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cancer and Cardiovascular Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for NK Cells industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, NK Cells key manufacturers include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc. Chipscreen Biosciences, Affimed NV, Altor BioScience are top 3 players and held % sales share in total in 2022.
NK Cells can be divided into Mogamulizumab, Lorvotuzumab Mertansine and Others,, etc. Mogamulizumab is the mainstream product in the market, accounting for % sales share globally in 2022.
NK Cells is widely used in various fields, such as Cancer, Cardiovascular Diseases and Others,, etc. Cancer provides greatest supports to the NK Cells industry development. In 2022, global % sales of NK Cells went into Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global NK Cells market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Fortress Biotech
Segment by Type
Mogamulizumab
Lorvotuzumab Mertansine
Others

Segment by Application


Cancer
Cardiovascular Diseases
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the NK Cells market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of NK Cells, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the NK Cells industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of NK Cells in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, NK Cells introduction, etc. NK Cells Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of NK Cells market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 NK Cells Market Overview
1.1 NK Cells Product Overview
1.2 NK Cells Market Segment by Type
1.2.1 Mogamulizumab
1.2.2 Lorvotuzumab Mertansine
1.2.3 Others
1.3 Global NK Cells Market Size by Type
1.3.1 Global NK Cells Market Size Overview by Type (2018-2034)
1.3.2 Global NK Cells Historic Market Size Review by Type (2018-2024)
1.3.3 Global NK Cells Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America NK Cells Sales Breakdown by Type (2018-2024)
1.4.2 Europe NK Cells Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific NK Cells Sales Breakdown by Type (2018-2024)
1.4.4 Latin America NK Cells Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa NK Cells Sales Breakdown by Type (2018-2024)
2 Global NK Cells Market Competition by Company
2.1 Global Top Players by NK Cells Sales (2018-2024)
2.2 Global Top Players by NK Cells Revenue (2018-2024)
2.3 Global Top Players by NK Cells Price (2018-2024)
2.4 Global Top Manufacturers NK Cells Manufacturing Base Distribution, Sales Area, Product Type
2.5 NK Cells Market Competitive Situation and Trends
2.5.1 NK Cells Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by NK Cells Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NK Cells as of 2022)
2.7 Date of Key Manufacturers Enter into NK Cells Market
2.8 Key Manufacturers NK Cells Product Offered
2.9 Mergers & Acquisitions, Expansion
3 NK Cells Status and Outlook by Region
3.1 Global NK Cells Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global NK Cells Historic Market Size by Region
3.2.1 Global NK Cells Sales in Volume by Region (2018-2024)
3.2.2 Global NK Cells Sales in Value by Region (2018-2024)
3.2.3 Global NK Cells Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global NK Cells Forecasted Market Size by Region
3.3.1 Global NK Cells Sales in Volume by Region (2024-2034)
3.3.2 Global NK Cells Sales in Value by Region (2024-2034)
3.3.3 Global NK Cells Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global NK Cells by Application
4.1 NK Cells Market Segment by Application
4.1.1 Cancer
4.1.2 Cardiovascular Diseases
4.1.3 Others
4.2 Global NK Cells Market Size by Application
4.2.1 Global NK Cells Market Size Overview by Application (2018-2034)
4.2.2 Global NK Cells Historic Market Size Review by Application (2018-2024)
4.2.3 Global NK Cells Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America NK Cells Sales Breakdown by Application (2018-2024)
4.3.2 Europe NK Cells Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific NK Cells Sales Breakdown by Application (2018-2024)
4.3.4 Latin America NK Cells Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa NK Cells Sales Breakdown by Application (2018-2024)
5 North America NK Cells by Country
5.1 North America NK Cells Historic Market Size by Country
5.1.1 North America NK Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America NK Cells Sales in Volume by Country (2018-2024)
5.1.3 North America NK Cells Sales in Value by Country (2018-2024)
5.2 North America NK Cells Forecasted Market Size by Country
5.2.1 North America NK Cells Sales in Volume by Country (2024-2034)
5.2.2 North America NK Cells Sales in Value by Country (2024-2034)
6 Europe NK Cells by Country
6.1 Europe NK Cells Historic Market Size by Country
6.1.1 Europe NK Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe NK Cells Sales in Volume by Country (2018-2024)
6.1.3 Europe NK Cells Sales in Value by Country (2018-2024)
6.2 Europe NK Cells Forecasted Market Size by Country
6.2.1 Europe NK Cells Sales in Volume by Country (2024-2034)
6.2.2 Europe NK Cells Sales in Value by Country (2024-2034)
7 Asia-Pacific NK Cells by Region
7.1 Asia-Pacific NK Cells Historic Market Size by Region
7.1.1 Asia-Pacific NK Cells Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific NK Cells Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific NK Cells Sales in Value by Region (2018-2024)
7.2 Asia-Pacific NK Cells Forecasted Market Size by Region
7.2.1 Asia-Pacific NK Cells Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific NK Cells Sales in Value by Region (2024-2034)
8 Latin America NK Cells by Country
8.1 Latin America NK Cells Historic Market Size by Country
8.1.1 Latin America NK Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America NK Cells Sales in Volume by Country (2018-2024)
8.1.3 Latin America NK Cells Sales in Value by Country (2018-2024)
8.2 Latin America NK Cells Forecasted Market Size by Country
8.2.1 Latin America NK Cells Sales in Volume by Country (2024-2034)
8.2.2 Latin America NK Cells Sales in Value by Country (2024-2034)
9 Middle East and Africa NK Cells by Country
9.1 Middle East and Africa NK Cells Historic Market Size by Country
9.1.1 Middle East and Africa NK Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa NK Cells Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa NK Cells Sales in Value by Country (2018-2024)
9.2 Middle East and Africa NK Cells Forecasted Market Size by Country
9.2.1 Middle East and Africa NK Cells Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa NK Cells Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Chipscreen Biosciences
10.1.1 Chipscreen Biosciences Company Information
10.1.2 Chipscreen Biosciences Introduction and Business Overview
10.1.3 Chipscreen Biosciences NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Chipscreen Biosciences NK Cells Products Offered
10.1.5 Chipscreen Biosciences Recent Development
10.2 Affimed NV
10.2.1 Affimed NV Company Information
10.2.2 Affimed NV Introduction and Business Overview
10.2.3 Affimed NV NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Affimed NV NK Cells Products Offered
10.2.5 Affimed NV Recent Development
10.3 Altor BioScience
10.3.1 Altor BioScience Company Information
10.3.2 Altor BioScience Introduction and Business Overview
10.3.3 Altor BioScience NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Altor BioScience NK Cells Products Offered
10.3.5 Altor BioScience Recent Development
10.4 Innate Pharma
10.4.1 Innate Pharma Company Information
10.4.2 Innate Pharma Introduction and Business Overview
10.4.3 Innate Pharma NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Innate Pharma NK Cells Products Offered
10.4.5 Innate Pharma Recent Development
10.5 Takeda
10.5.1 Takeda Company Information
10.5.2 Takeda Introduction and Business Overview
10.5.3 Takeda NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Takeda NK Cells Products Offered
10.5.5 Takeda Recent Development
10.6 Sorrento Therapeutics
10.6.1 Sorrento Therapeutics Company Information
10.6.2 Sorrento Therapeutics Introduction and Business Overview
10.6.3 Sorrento Therapeutics NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sorrento Therapeutics NK Cells Products Offered
10.6.5 Sorrento Therapeutics Recent Development
10.7 NantKwest
10.7.1 NantKwest Company Information
10.7.2 NantKwest Introduction and Business Overview
10.7.3 NantKwest NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.7.4 NantKwest NK Cells Products Offered
10.7.5 NantKwest Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Information
10.8.2 Bristol-Myers Squibb Introduction and Business Overview
10.8.3 Bristol-Myers Squibb NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bristol-Myers Squibb NK Cells Products Offered
10.8.5 Bristol-Myers Squibb Recent Development
10.9 NKT
10.9.1 NKT Company Information
10.9.2 NKT Introduction and Business Overview
10.9.3 NKT NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.9.4 NKT NK Cells Products Offered
10.9.5 NKT Recent Development
10.10 Henry Ford Health Services
10.10.1 Henry Ford Health Services Company Information
10.10.2 Henry Ford Health Services Introduction and Business Overview
10.10.3 Henry Ford Health Services NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Henry Ford Health Services NK Cells Products Offered
10.10.5 Henry Ford Health Services Recent Development
10.11 Fortress Biotech
10.11.1 Fortress Biotech Company Information
10.11.2 Fortress Biotech Introduction and Business Overview
10.11.3 Fortress Biotech NK Cells Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Fortress Biotech NK Cells Products Offered
10.11.5 Fortress Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 NK Cells Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 NK Cells Industrial Chain Analysis
11.4 NK Cells Market Dynamics
11.4.1 NK Cells Industry Trends
11.4.2 NK Cells Market Drivers
11.4.3 NK Cells Market Challenges
11.4.4 NK Cells Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 NK Cells Distributors
12.3 NK Cells Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Mogamulizumab
Table 2. Major Company of Lorvotuzumab Mertansine
Table 3. Major Company of Others
Table 4. Global NK Cells Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global NK Cells Sales by Type (2018-2024) & (g)
Table 6. Global NK Cells Sales Market Share in Volume by Type (2018-2024)
Table 7. Global NK Cells Sales by Type (2018-2024) & (US& Million)
Table 8. Global NK Cells Market Share in Value by Type (2018-2024)
Table 9. Global NK Cells Price by Type (2018-2024) & (USD/g)
Table 10. Global NK Cells Sales by Type (2024-2034) & (g)
Table 11. Global NK Cells Sales Market Share in Volume by Type (2024-2034)
Table 12. Global NK Cells Sales by Type (2024-2034) & (US$ Million)
Table 13. Global NK Cells Sales Market Share in Value by Type (2024-2034)
Table 14. Global NK Cells Price by Type (2024-2034) & (USD/g)
Table 15. North America NK Cells Sales by Type (2018-2024) & (g)
Table 16. North America NK Cells Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe NK Cells Sales (g) by Type (2018-2024)
Table 18. Europe NK Cells Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific NK Cells Sales (g) by Type (2018-2024)
Table 20. Asia-Pacific NK Cells Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America NK Cells Sales (g) by Type (2018-2024)
Table 22. Latin America NK Cells Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa NK Cells Sales (g) by Type (2018-2024)
Table 24. Middle East and Africa NK Cells Sales by Type (2018-2024) & (US$ Million)
Table 25. Global NK Cells Sales by Company (2018-2024) & (g)
Table 26. Global NK Cells Sales Share by Company (2018-2024)
Table 27. Global NK Cells Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global NK Cells Revenue Share by Company (2018-2024)
Table 29. Global Market NK Cells Price by Company (2018-2024) & (USD/g)
Table 30. Global NK Cells Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global NK Cells Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NK Cells as of 2022)
Table 33. Date of Key Manufacturers Enter into NK Cells Market
Table 34. Key Manufacturers NK Cells Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global NK Cells Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global NK Cells Sales by Region (2018-2024) & (g)
Table 38. Global NK Cells Sales Market Share in Volume by Region (2018-2024)
Table 39. Global NK Cells Sales by Region (2018-2024) & (US$ Million)
Table 40. Global NK Cells Sales Market Share in Value by Region (2018-2024)
Table 41. Global NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 42. Global NK Cells Sales by Region (2024-2034) & (g)
Table 43. Global NK Cells Sales Market Share in Volume by Region (2024-2034)
Table 44. Global NK Cells Sales by Region (2024-2034) & (US$ Million)
Table 45. Global NK Cells Sales Market Share in Value by Region (2024-2034)
Table 46. Global NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2024-2034)
Table 47. Global NK Cells Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global NK Cells Sales by Application (2018-2024) & (g)
Table 49. Global NK Cells Sales Market Share in Volume by Application (2018-2024)
Table 50. Global NK Cells Sales by Application (2018-2024) & (US$ Million)
Table 51. Global NK Cells Sales Market Share in Value by Application (2018-2024)
Table 52. Global NK Cells Price by Application (2018-2024) & (USD/g)
Table 53. Global NK Cells Sales by Application (2024-2034) & (g)
Table 54. Global NK Cells Sales Market Share in Volume by Application (2024-2034)
Table 55. Global NK Cells Sales by Application (2024-2034) & (US$ Million)
Table 56. Global NK Cells Sales Market Share in Value by Application (2024-2034)
Table 57. Global NK Cells Price by Application (2024-2034) & (USD/g)
Table 58. North America NK Cells Sales by Application (2018-2024) (g)
Table 59. North America NK Cells Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe NK Cells Sales by Application (2018-2024) (g)
Table 61. Europe NK Cells Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific NK Cells Sales by Application (2018-2024) (g)
Table 63. Asia-Pacific NK Cells Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America NK Cells Sales by Application (2018-2024) (g)
Table 65. Latin America NK Cells Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa NK Cells Sales by Application (2018-2024) (g)
Table 67. Middle East and Africa NK Cells Sales by Application (2018-2024) & (US$ Million)
Table 68. North America NK Cells Sales by Country (2018-2024) & (g)
Table 69. North America NK Cells Sales Market Share in Volume by Country (2018-2024)
Table 70. North America NK Cells Sales by Country (2018-2024) & (US$ Million)
Table 71. North America NK Cells Sales Market Share in Value by Country (2018-2024)
Table 72. North America NK Cells Sales by Country (2024-2034) & (g)
Table 73. North America NK Cells Sales Market Share in Volume by Country (2024-2034)
Table 74. North America NK Cells Sales by Country (2024-2034) & (US$ Million)
Table 75. North America NK Cells Sales Market Share in Value by Country (2024-2034)
Table 76. Europe NK Cells Sales by Country (2018-2024) & (g)
Table 77. Europe NK Cells Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe NK Cells Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe NK Cells Sales Market Share in Value by Country (2018-2024)
Table 80. Europe NK Cells Sales by Country (2024-2034) & (g)
Table 81. Europe NK Cells Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe NK Cells Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe NK Cells Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific NK Cells Sales by Region (2018-2024) & (g)
Table 85. Asia-Pacific NK Cells Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific NK Cells Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific NK Cells Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific NK Cells Sales by Region (2024-2034) & (g)
Table 89. Asia-Pacific NK Cells Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific NK Cells Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific NK Cells Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America NK Cells Sales by Country (2018-2024) & (g)
Table 93. Latin America NK Cells Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America NK Cells Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America NK Cells Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America NK Cells Sales by Country (2024-2034) & (g)
Table 97. Latin America NK Cells Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America NK Cells Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America NK Cells Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa NK Cells Sales by Country (2018-2024) & (g)
Table 101. Middle East and Africa NK Cells Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa NK Cells Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa NK Cells Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa NK Cells Sales by Country (2024-2034) & (g)
Table 105. Middle East and Africa NK Cells Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa NK Cells Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa NK Cells Sales Market Share in Value by Country (2024-2034)
Table 108. Chipscreen Biosciences Company Information
Table 109. Chipscreen Biosciences Introduction and Business Overview
Table 110. Chipscreen Biosciences NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 111. Chipscreen Biosciences NK Cells Product
Table 112. Chipscreen Biosciences Recent Development
Table 113. Affimed NV Company Information
Table 114. Affimed NV Introduction and Business Overview
Table 115. Affimed NV NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 116. Affimed NV NK Cells Product
Table 117. Affimed NV Recent Development
Table 118. Altor BioScience Company Information
Table 119. Altor BioScience Introduction and Business Overview
Table 120. Altor BioScience NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 121. Altor BioScience NK Cells Product
Table 122. Altor BioScience Recent Development
Table 123. Innate Pharma Company Information
Table 124. Innate Pharma Introduction and Business Overview
Table 125. Innate Pharma NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 126. Innate Pharma NK Cells Product
Table 127. Innate Pharma Recent Development
Table 128. Takeda Company Information
Table 129. Takeda Introduction and Business Overview
Table 130. Takeda NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 131. Takeda NK Cells Product
Table 132. Takeda Recent Development
Table 133. Sorrento Therapeutics Company Information
Table 134. Sorrento Therapeutics Introduction and Business Overview
Table 135. Sorrento Therapeutics NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 136. Sorrento Therapeutics NK Cells Product
Table 137. Sorrento Therapeutics Recent Development
Table 138. NantKwest Company Information
Table 139. NantKwest Introduction and Business Overview
Table 140. NantKwest NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 141. NantKwest NK Cells Product
Table 142. NantKwest Recent Development
Table 143. Bristol-Myers Squibb Company Information
Table 144. Bristol-Myers Squibb Introduction and Business Overview
Table 145. Bristol-Myers Squibb NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 146. Bristol-Myers Squibb NK Cells Product
Table 147. Bristol-Myers Squibb Recent Development
Table 148. NKT Company Information
Table 149. NKT Introduction and Business Overview
Table 150. NKT NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 151. NKT NK Cells Product
Table 152. NKT Recent Development
Table 153. Henry Ford Health Services Company Information
Table 154. Henry Ford Health Services Introduction and Business Overview
Table 155. Henry Ford Health Services NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 156. Henry Ford Health Services NK Cells Product
Table 157. Henry Ford Health Services Recent Development
Table 158. Fortress Biotech Company Information
Table 159. Fortress Biotech Introduction and Business Overview
Table 160. Fortress Biotech NK Cells Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2018-2024)
Table 161. Fortress Biotech NK Cells Product
Table 162. Fortress Biotech Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. NK Cells Market Trends
Table 166. NK Cells Market Drivers
Table 167. NK Cells Market Challenges
Table 168. NK Cells Market Restraints
Table 169. NK Cells Distributors List
Table 170. NK Cells Downstream Customers
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. NK Cells Product Picture
Figure 2. Global NK Cells Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global NK Cells Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global NK Cells Sales Status and Outlook (2018-2034) & (g)
Figure 5. Product Picture of Mogamulizumab
Figure 6. Global Mogamulizumab Sales YoY Growth (2018-2034) & (g)
Figure 7. Product Picture of Lorvotuzumab Mertansine
Figure 8. Global Lorvotuzumab Mertansine Sales YoY Growth (2018-2034) & (g)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (g)
Figure 11. Global NK Cells Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global NK Cells Sales Market Share by Type in 2022 & 2034
Figure 13. North America NK Cells Sales Market Share in Volume by Type in 2022
Figure 14. North America NK Cells Sales Market Share in Value by Type in 2022
Figure 15. Europe NK Cells Sales Market Share in Volume by Type in 2022
Figure 16. Europe NK Cells Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific NK Cells Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific NK Cells Sales Market Share in Value by Type in 2022
Figure 19. Latin America NK Cells Sales Market Share in Volume by Type in 2022
Figure 20. Latin America NK Cells Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa NK Cells Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa NK Cells Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by NK Cells Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by NK Cells Revenue in 2022
Figure 25. NK Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Cancer
Figure 27. Global Cancer Sales YoY Growth (2018-2034) & (g)
Figure 28. Product Picture of Cardiovascular Diseases
Figure 29. Global Cardiovascular Diseases Sales YoY Growth (2018-2034) & (g)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (g)
Figure 32. Global NK Cells Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global NK Cells Sales Market Share by Application in 2022 & 2034
Figure 34. North America NK Cells Sales Market Share in Volume by Application in 2022
Figure 35. North America NK Cells Sales Market Share in Value by Application in 2022
Figure 36. Europe NK Cells Sales Market Share in Volume by Application in 2022
Figure 37. Europe NK Cells Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific NK Cells Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific NK Cells Sales Market Share in Value by Application in 2022
Figure 40. Latin America NK Cells Sales Market Share in Volume by Application in 2022
Figure 41. Latin America NK Cells Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa NK Cells Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. NK Cells Manufacturing Cost Structure
Figure 45. NK Cells Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries